James Lanthier is the CEO of Singularity Pharma, a seasoned executive with a strong background in technology and life sciences. He has a proven track record of leading companies from inception to successful exit, specializing in drug discovery and development within the biotechnology sector.
Based in the Toronto area, James has deep connections to the local business and academic communities, including an affiliation with the University of Torontos Rotman School of Management. He values collaboration and partnership as key drivers for success in the demanding pharmaceutical industry.
He successfully led Mindset Pharma as CEO, culminating in its acquisition by Otsuka Pharmaceuticals for approximately CAD $80 million in 2023.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.